Sintx Technologies Inc. (SINT)
NASDAQ: SINT
· Real-Time Price · USD
2.47
-0.03 (-1.20%)
At close: May 08, 2025, 3:17 PM
Company Description
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States.
The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone.
The company was formerly known as Amedica Corporation.
Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Sintx Technologies Inc.

Country | United States |
IPO Date | Feb 13, 2014 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 20 |
CEO | Eric K. Olson |
Contact Details
Address: 1885 West 2100 South Salt Lake City, Utah United States | |
Website | https://www.sintx.com |
Stock Details
Ticker Symbol | SINT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001269026 |
CUSIP Number | 829392307 |
ISIN Number | US8293926049 |
Employer ID | 00-0000000 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Eric K. Olson | President, Chief Executive Officer & Chairman of the Board |
Dr. Ryan Bock Ph.D. | Chief Technology Officer |
Gregg Richard Honigblum | Chief Investment Officer & Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 07, 2025 | 8-K | Current Report |
May 01, 2025 | 4 | Filing |
Apr 30, 2025 | 4 | Filing |
Apr 30, 2025 | 4 | Filing |
Apr 30, 2025 | 3 | Filing |
Apr 30, 2025 | 3 | Filing |
Apr 08, 2025 | 8-K | Current Report |
Mar 25, 2025 | SCHEDULE 13G | Filing |
Mar 25, 2025 | S-3/A | [Amend] Filing |
Mar 19, 2025 | S-3 | Filing |